Radioimmunoprecipitation assay for glutamic acid decarboxylase antibodies evaluated clinically with sera from patients with insulin- dependent diabetes mellitus

Clinical Chemistry

Volumn 42, Issue 12, 1996, Pages 1975-1978

  Ohta, Mitsuhiro ^a   Obayashi, Hiroshi ^b   Takahashi, Kenji ^c   Kitagawa, Yoshihiro ^d   Nakano, Koji ^d   Matsuo, Satoshi ^d   Nishimura, Masataka ^a   Itoh, Nobuyuki ^e   Ohta, Kiyoe ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b Kyoto Microbiological Institute   (Japan)

^c KURASHIKI CENTRAL HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

autoantibodies; insulin deficiency; recombinant analyte

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; INSULIN; IODINE 125; RECOMBINANT PROTEIN;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIOIMMUNOPRECIPITATION; SCREENING TEST; SERUM;

EID: 0029852936     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.12.1975     Document Type: Article

References (13)

1. Palmer JP. What is the best way to predict IDDM? [Commentary]. Lancet 1994;343:1377-8.
2. 65) shows that 64K autoantibody positivity at onset predicts diabetes type. J Clin Invest 1993;91:368-74.
3. r autoantibody as predictor of insulin-dependent diabetes. Lancet 1990;335:1357-60.
4. r autoantibodies. Diabetes 1992;41: 1355-9.
5. Schmidli RS, Colman PG, Bonifacio E, participating laboratories. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GAD Ab Workshop. Diabetes 1995;44:636-40.
6. 65 autoantibodies, a key risk assessment marker for insulin-dependent diabetes mellitus. Clin Chem 1996;42:263-9.
7. Bakos S, Mackey IR, Rowley MJ, Knowles W, Zimmet P. Islet cell antibodies and other markers of autoimmunity and diabetes mellitus in Nauruans. Diabetologia 1991;34:796-800.
8. Ohta M, Obayashi H, Takahashi K, Kitagawa Y, Nakano K, Matsuo S, et al. A simple solid-phase radioimmunoassay for glutamic acid decarboxylase (GAD) antibodies in patients with diabetes mellitus. J Clin Biochem Nutr 1996;20:139-48.
9. Ohta M, Obayashi H, Ichimura T, Nishimura M, Itoh N, Ohta K. Immunological characterization of antibodies against synthetic peptides of glutamic acid decarboxylase. Clin Chim Acta 1996; 251:81-9.
10. Obayashi H, Ohta M, Kitagawa Y, Nakamura N, Nakano K, Kondo M, et al. Determination of autoantibodies to two forms (65 kDa, 67 kDa) of glutamic acid decarboxylase by Western blot analysis with immunopurified antigens, and their clinical evaluation. J Jpn Diabetes Soc 1994;37:23-30.
11. Hagopian W, Lernmark A. Autoimmune diabetes mellitus. In: Rose NE, Mackay IR, eds. The autoimmune diseases II. New York: Academic Press, 1992:235-78.
12. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay I. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993;42:359-62.
13. r 65 000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994;19:113-25.